Fifth Third Bancorp Reduces Stock Position in Humana Inc. (NYSE:HUM)

Fifth Third Bancorp reduced its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 37.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,194 shares of the insurance provider's stock after selling 4,368 shares during the period. Fifth Third Bancorp's holdings in Humana were worth $1,825,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. FNY Investment Advisers LLC increased its position in shares of Humana by 6,647.5% during the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock worth $6,916,000 after purchasing an additional 26,856 shares during the last quarter. PDT Partners LLC raised its position in Humana by 190.0% during the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider's stock worth $1,286,000 after acquiring an additional 2,660 shares in the last quarter. Secure Asset Management LLC acquired a new stake in Humana in the fourth quarter valued at $244,000. Ontario Teachers Pension Plan Board grew its position in shares of Humana by 6.5% in the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider's stock valued at $371,705,000 after acquiring an additional 71,910 shares during the period. Finally, Swedbank AB increased its stake in shares of Humana by 3.0% during the 3rd quarter. Swedbank AB now owns 105,976 shares of the insurance provider's stock worth $33,567,000 after purchasing an additional 3,085 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Down 2.9 %

Humana stock traded down $8.93 during midday trading on Wednesday, reaching $294.18. The stock had a trading volume of 1,252,247 shares, compared to its average volume of 1,553,639. The company has a market capitalization of $35.42 billion, a P/E ratio of 26.06, a PEG ratio of 2.15 and a beta of 0.55. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a fifty day moving average price of $275.44 and a two-hundred day moving average price of $303.14. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, equities analysts expect that Humana Inc. will post 16.11 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on HUM shares. Morgan Stanley lifted their price objective on shares of Humana from $288.00 to $301.00 and gave the stock an "equal weight" rating in a research report on Tuesday, December 17th. Leerink Partners downgraded shares of Humana from an "outperform" rating to a "market perform" rating and reduced their target price for the stock from $400.00 to $250.00 in a report on Wednesday, October 2nd. Cantor Fitzgerald reissued a "neutral" rating and issued a $395.00 price target on shares of Humana in a report on Tuesday, October 1st. TD Cowen boosted their price objective on Humana from $261.00 to $268.00 and gave the stock a "hold" rating in a report on Monday, November 4th. Finally, Bank of America upgraded Humana from an "underperform" rating to a "neutral" rating and increased their target price for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. Nineteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $297.68.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the business's stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.32% of the stock is owned by insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.